APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alzheimer's Disease Drug

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Selected research

Industry Growth & Trends

Global Alzheimer's Disease Drug Industry Growth and Trends Forecast to 2032

2 January 202695 pages

Choose your research edition.

Industry ResearchAlzheimer's Disease Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Alzheimer's Disease Drug Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Alzheimer's Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alzheimer's Disease Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Alzheimer's Disease Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Alzheimer's Disease Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alzheimer's Disease Drug market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alzheimer's Disease Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alzheimer's Disease Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alzheimer's Disease Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alzheimer's Disease Drug Market by Company

Allergan

Eisai

Novartis

Daiichi Sankyo

Merz Pharma

Pfizer

Johnson & Johnson

Lundbeck

Alzheimer's Disease Drug Segment by Type

Donepezil

Memantine

Rivastigmine

Others

Alzheimer's Disease Drug Segment by Application

Early to Moderate Stages

Moderate to Severe Stages

Alzheimer's Disease Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alzheimer's Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alzheimer's Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alzheimer's Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alzheimer's Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Donepezil Table 2. Major Company of Memantine Table 3. Major Company of Rivastigmine Table 4. Major Company of Others Table 5. Global Alzheimer's Disease Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Alzheimer's Disease Drug Sales by Type (2021-2026) & (M Units) Table 7. Global Alzheimer's Disease Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Alzheimer's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Alzheimer's Disease Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Alzheimer's Disease Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Alzheimer's Disease Drug Sales by Type (2027-2032) & (M Units) Table 12. Global Alzheimer's Disease Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Alzheimer's Disease Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Alzheimer's Disease Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Alzheimer's Disease Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Alzheimer's Disease Drug Sales by Type (2021-2026) & (M Units) Table 17. North America Alzheimer's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Alzheimer's Disease Drug Sales by Type (2021-2026) & (M Units) Table 19. Europe Alzheimer's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Alzheimer's Disease Drug Sales by Type (2021-2026) & (M Units) Table 21. Asia-Pacific Alzheimer's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Alzheimer's Disease Drug Sales by Type (2021-2026) & (M Units) Table 23. Latin America Alzheimer's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2021-2026) & (M Units) Table 25. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Alzheimer's Disease Drug Industry Trends Table 27. Alzheimer's Disease Drug Industry Drivers Table 28. Alzheimer's Disease Drug Industry Opportunities and Challenges Table 29. Alzheimer's Disease Drug Industry Restraints Table 30. Global Alzheimer's Disease Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Alzheimer's Disease Drug Revenue Market Share by Company (2021-2026) Table 32. Global Alzheimer's Disease Drug Sales by Company (2021-2026) & (M Units) Table 33. Global Alzheimer's Disease Drug Sales Share by Company (2021-2026) Table 34. Global Alzheimer's Disease Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Alzheimer's Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Alzheimer's Disease Drug Major Company Production Sites and Headquarters Table 37. Global Alzheimer's Disease Drug Company, Product Type & Application Table 38. Global Alzheimer's Disease Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Alzheimer's Disease Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Alzheimer's Disease Drug Sales by Region (2021-2026) & (M Units) Table 43. Global Alzheimer's Disease Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Alzheimer's Disease Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Alzheimer's Disease Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Alzheimer's Disease Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Alzheimer's Disease Drug Sales by Region (2027-2032) & (M Units) Table 48. Global Alzheimer's Disease Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Alzheimer's Disease Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Alzheimer's Disease Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Alzheimer's Disease Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Alzheimer's Disease Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Alzheimer's Disease Drug Sales by Application (2021-2026) & (M Units) Table 54. Global Alzheimer's Disease Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Alzheimer's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Alzheimer's Disease Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Alzheimer's Disease Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Alzheimer's Disease Drug Sales by Application (2027-2032) & (M Units) Table 59. Global Alzheimer's Disease Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Alzheimer's Disease Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Alzheimer's Disease Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Alzheimer's Disease Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Alzheimer's Disease Drug Sales by Application (2021-2026) & (M Units) Table 64. North America Alzheimer's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Alzheimer's Disease Drug Sales by Application (2021-2026) & (M Units) Table 66. Europe Alzheimer's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Alzheimer's Disease Drug Sales by Application (2021-2026) & (M Units) Table 68. Asia-Pacific Alzheimer's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Alzheimer's Disease Drug Sales by Application (2021-2026) & (M Units) Table 70. Latin America Alzheimer's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2021-2026) & (M Units) Table 72. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Allergan Company Information Table 74. Allergan Business Overview Table 75. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Allergan Alzheimer's Disease Drug Product Portfolio Table 77. Allergan Recent Development Table 78. Eisai Company Information Table 79. Eisai Business Overview Table 80. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Eisai Alzheimer's Disease Drug Product Portfolio Table 82. Eisai Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novartis Alzheimer's Disease Drug Product Portfolio Table 87. Novartis Recent Development Table 88. Daiichi Sankyo Company Information Table 89. Daiichi Sankyo Business Overview Table 90. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Daiichi Sankyo Alzheimer's Disease Drug Product Portfolio Table 92. Daiichi Sankyo Recent Development Table 93. Merz Pharma Company Information Table 94. Merz Pharma Business Overview Table 95. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Merz Pharma Alzheimer's Disease Drug Product Portfolio Table 97. Merz Pharma Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Pfizer Alzheimer's Disease Drug Product Portfolio Table 102. Pfizer Recent Development Table 103. Johnson & Johnson Company Information Table 104. Johnson & Johnson Business Overview Table 105. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Johnson & Johnson Alzheimer's Disease Drug Product Portfolio Table 107. Johnson & Johnson Recent Development Table 108. Lundbeck Company Information Table 109. Lundbeck Business Overview Table 110. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Lundbeck Alzheimer's Disease Drug Product Portfolio Table 112. Lundbeck Recent Development Table 113. North America Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 114. North America Alzheimer's Disease Drug Sales by Country (2021-2026) & (M Units) Table 115. North America Alzheimer's Disease Drug Sales Market Share by Country (2021-2026) Table 116. North America Alzheimer's Disease Drug Sales Forecast by Country (2027-2032) & (M Units) Table 117. North America Alzheimer's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 118. North America Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Alzheimer's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Alzheimer's Disease Drug Market Share by Country (2021-2026) Table 121. North America Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Alzheimer's Disease Drug Market Share Forecast by Country (2027-2032) Table 123. Europe Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 124. Europe Alzheimer's Disease Drug Sales by Country (2021-2026) & (M Units) Table 125. Europe Alzheimer's Disease Drug Sales Market Share by Country (2021-2026) Table 126. Europe Alzheimer's Disease Drug Sales Forecast by Country (2027-2032) & (M Units) Table 127. Europe Alzheimer's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Alzheimer's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Alzheimer's Disease Drug Market Share by Country (2021-2026) Table 131. Europe Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Alzheimer's Disease Drug Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Alzheimer's Disease Drug Sales by Country (2021-2026) & (M Units) Table 135. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Alzheimer's Disease Drug Sales Forecast by Country (2027-2032) & (M Units) Table 137. Asia-Pacific Alzheimer's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Alzheimer's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Alzheimer's Disease Drug Market Share by Country (2021-2026) Table 141. Asia-Pacific Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Alzheimer's Disease Drug Market Share Forecast by Country (2027-2032) Table 143. Latin America Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 144. Latin America Alzheimer's Disease Drug Sales by Country (2021-2026) & (M Units) Table 145. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2021-2026) Table 146. Latin America Alzheimer's Disease Drug Sales Forecast by Country (2027-2032) & (M Units) Table 147. Latin America Alzheimer's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Alzheimer's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Alzheimer's Disease Drug Market Share by Country (2021-2026) Table 151. Latin America Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Alzheimer's Disease Drug Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2021-2026) & (M Units) Table 155. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Alzheimer's Disease Drug Sales Forecast by Country (2027-2032) & (M Units) Table 157. Middle East and Africa Alzheimer's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Alzheimer's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Alzheimer's Disease Drug Market Share by Country (2021-2026) Table 161. Middle East and Africa Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Alzheimer's Disease Drug Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Alzheimer's Disease Drug Distributors List Table 166. Alzheimer's Disease Drug Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Alzheimer's Disease Drug Image Figure 2. Global Alzheimer's Disease Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alzheimer's Disease Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Alzheimer's Disease Drug Sales (2021-2032) & (M Units) Figure 5. Donepezil Image Figure 6. Global Donepezil Sales YoY Growth (2021-2032) & (M Units) Figure 7. Memantine Image Figure 8. Global Memantine Sales YoY Growth (2021-2032) & (M Units) Figure 9. Rivastigmine Image Figure 10. Global Rivastigmine Sales YoY Growth (2021-2032) & (M Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 13. Global Alzheimer's Disease Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Alzheimer's Disease Drug Market Share by Type 2025 VS 2032 Figure 15. North America Alzheimer's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Alzheimer's Disease Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Alzheimer's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Alzheimer's Disease Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Alzheimer's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Alzheimer's Disease Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Alzheimer's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Alzheimer's Disease Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Alzheimer's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Alzheimer's Disease Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Alzheimer's Disease Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Early to Moderate Stages Image Figure 28. Global Early to Moderate Stages Sales YoY Growth (2021-2032) & (M Units) Figure 29. Moderate to Severe Stages Image Figure 30. Global Moderate to Severe Stages Sales YoY Growth (2021-2032) & (M Units) Figure 31. Global Alzheimer's Disease Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Alzheimer's Disease Drug Market Share by Application 2025 VS 2032 Figure 33. North America Alzheimer's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Alzheimer's Disease Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Alzheimer's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Alzheimer's Disease Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Alzheimer's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Alzheimer's Disease Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Alzheimer's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Alzheimer's Disease Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Alzheimer's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Alzheimer's Disease Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Alzheimer's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 44. North America Alzheimer's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Alzheimer's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Alzheimer's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Alzheimer's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. Europe Alzheimer's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Alzheimer's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Alzheimer's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Alzheimer's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Asia-Pacific Alzheimer's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Alzheimer's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Alzheimer's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Alzheimer's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Latin America Alzheimer's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Alzheimer's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Alzheimer's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Alzheimer's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 60. Middle East and Africa Alzheimer's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Alzheimer's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Alzheimer's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Alzheimer's Disease Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Alzheimer's Disease Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Donepezil
  • Memantine
  • Rivastigmine
  • Others
Applications
  • Early to Moderate Stages
  • Moderate to Severe Stages
Companies covered
  • Allergan
  • Eisai
  • Novartis
  • Daiichi Sankyo
  • Merz Pharma
  • Pfizer
  • Johnson & Johnson
  • Lundbeck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alzheimer's Disease Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alzheimer's Disease Drug Market by Type
  6. 1.3.1 Donepezil
  7. 1.3.2 Memantine
  8. 1.3.3 Rivastigmine
  9. 1.3.4 Others
  10. 1.4 Global Alzheimer's Disease Drug Market Size by Type
  11. 1.4.1 Global Alzheimer's Disease Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Alzheimer's Disease Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Alzheimer's Disease Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Alzheimer's Disease Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Alzheimer's Disease Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Alzheimer's Disease Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Alzheimer's Disease Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Alzheimer's Disease Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alzheimer's Disease Drug Industry Trends
  2. 2.2 Alzheimer's Disease Drug Industry Drivers
  3. 2.3 Alzheimer's Disease Drug Industry Opportunities and Challenges
  4. 2.4 Alzheimer's Disease Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alzheimer's Disease Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Alzheimer's Disease Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Alzheimer's Disease Drug Price (2021-2026)
  4. 3.4 Global Alzheimer's Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alzheimer's Disease Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Alzheimer's Disease Drug Company, Product Type & Application
  7. 3.7 Global Alzheimer's Disease Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alzheimer's Disease Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alzheimer's Disease Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alzheimer's Disease Drug Tier 1, Tier 2, and Tier 3
4 Alzheimer's Disease Drug Regional Status and Outlook
  1. 4.1 Global Alzheimer's Disease Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alzheimer's Disease Drug Historic Market Size by Region
  3. 4.2.1 Global Alzheimer's Disease Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alzheimer's Disease Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alzheimer's Disease Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alzheimer's Disease Drug Forecasted Market Size by Region
  7. 4.3.1 Global Alzheimer's Disease Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alzheimer's Disease Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alzheimer's Disease Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alzheimer's Disease Drug by Application
  1. 5.1 Alzheimer's Disease Drug Market by Application
  2. 5.1.1 Early to Moderate Stages
  3. 5.1.2 Moderate to Severe Stages
  4. 5.2 Global Alzheimer's Disease Drug Market Size by Application
  5. 5.2.1 Global Alzheimer's Disease Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Alzheimer's Disease Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Alzheimer's Disease Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Alzheimer's Disease Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Alzheimer's Disease Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Alzheimer's Disease Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Alzheimer's Disease Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Alzheimer's Disease Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Allergan
  2. 6.1.1 Allergan Company Information
  3. 6.1.2 Allergan Business Overview
  4. 6.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Allergan Alzheimer's Disease Drug Product Portfolio
  6. 6.1.5 Allergan Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Alzheimer's Disease Drug Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Alzheimer's Disease Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Daiichi Sankyo
  20. 6.4.1 Daiichi Sankyo Company Information
  21. 6.4.2 Daiichi Sankyo Business Overview
  22. 6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Portfolio
  24. 6.4.5 Daiichi Sankyo Recent Developments
  25. 6.5 Merz Pharma
  26. 6.5.1 Merz Pharma Company Information
  27. 6.5.2 Merz Pharma Business Overview
  28. 6.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merz Pharma Alzheimer's Disease Drug Product Portfolio
  30. 6.5.5 Merz Pharma Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Alzheimer's Disease Drug Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Johnson & Johnson
  38. 6.7.1 Johnson & Johnson Company Information
  39. 6.7.2 Johnson & Johnson Business Overview
  40. 6.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Johnson & Johnson Alzheimer's Disease Drug Product Portfolio
  42. 6.7.5 Johnson & Johnson Recent Developments
  43. 6.8 Lundbeck
  44. 6.8.1 Lundbeck Company Information
  45. 6.8.2 Lundbeck Business Overview
  46. 6.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lundbeck Alzheimer's Disease Drug Product Portfolio
  48. 6.8.5 Lundbeck Recent Developments
7 North America by Country
  1. 7.1 North America Alzheimer's Disease Drug Sales by Country
  2. 7.1.1 North America Alzheimer's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alzheimer's Disease Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Alzheimer's Disease Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alzheimer's Disease Drug Market Size by Country
  6. 7.2.1 North America Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alzheimer's Disease Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alzheimer's Disease Drug Sales by Country
  2. 8.1.1 Europe Alzheimer's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alzheimer's Disease Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Alzheimer's Disease Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alzheimer's Disease Drug Market Size by Country
  6. 8.2.1 Europe Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alzheimer's Disease Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alzheimer's Disease Drug Sales by Country
  2. 9.1.1 Asia-Pacific Alzheimer's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alzheimer's Disease Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alzheimer's Disease Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alzheimer's Disease Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alzheimer's Disease Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alzheimer's Disease Drug Sales by Country
  2. 10.1.1 South America Alzheimer's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alzheimer's Disease Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Alzheimer's Disease Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alzheimer's Disease Drug Market Size by Country
  6. 10.2.1 South America Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alzheimer's Disease Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alzheimer's Disease Drug Sales by Country
  2. 11.1.1 Middle East and Africa Alzheimer's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alzheimer's Disease Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alzheimer's Disease Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Alzheimer's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alzheimer's Disease Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alzheimer's Disease Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alzheimer's Disease Drug Value Chain Analysis
  2. 12.1.1 Alzheimer's Disease Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alzheimer's Disease Drug Production Mode & Process
  7. 12.2 Alzheimer's Disease Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alzheimer's Disease Drug Distributors
  10. 12.2.3 Alzheimer's Disease Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst